Etavopivat improves hematologic and hemolytic parameters in patients with sickle cell disease June 21, 2021 No Comments
FDA lifts clinical hold on studies of LentiGlobin in sickle cell disease and beta-thalassemia June 8, 2021 No Comments
SPK-10000, a liver-targeted gene therapy for the treatment of hereditary angioedema June 1, 2021 No Comments
Phase I trial explores use of BIVV-001 in adults with type 2N and 3 von Willebrand disease May 31, 2021 No Comments